Clinical Trial Update: Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil) [Phase 4]

View source ↗

Summary

Phase 4 trial update indicates that insulin glargine (Lantus) provides benefits in Japanese patients outside Japan (US or Brazil) with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED